Kyoko Kato

820 total citations
63 papers, 598 citations indexed

About

Kyoko Kato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Kyoko Kato has authored 63 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Kyoko Kato's work include Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Treatments and Studies (12 papers) and Plant Water Relations and Carbon Dynamics (7 papers). Kyoko Kato is often cited by papers focused on Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Treatments and Studies (12 papers) and Plant Water Relations and Carbon Dynamics (7 papers). Kyoko Kato collaborates with scholars based in Japan, United States and South Korea. Kyoko Kato's co-authors include Hirohisa Tsuda, Shin‐Ichi Yamamoto, Shigenori Kadowaki, Kei Muro, Kazunori Honda, Toshiki Masuishi, Takao Setoguti, Masashi Ando, Yukiya Narita and Seiichiro Mitani and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Geophysical Research Atmospheres.

In The Last Decade

Kyoko Kato

60 papers receiving 574 citations

Peers

Kyoko Kato
Yihua Wu China
Jiaying Chen China
Xuemei Guo China
Yesha Patel United States
Zita Bognár Hungary
Chunfeng Yang China
Lillemor Lewan Sweden
Lisa A. Bailey United States
Xiaoge Wang China
John Lindsley United States
Yihua Wu China
Kyoko Kato
Citations per year, relative to Kyoko Kato Kyoko Kato (= 1×) peers Yihua Wu

Countries citing papers authored by Kyoko Kato

Since Specialization
Citations

This map shows the geographic impact of Kyoko Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Kato more than expected).

Fields of papers citing papers by Kyoko Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Kato. The network helps show where Kyoko Kato may publish in the future.

Co-authorship network of co-authors of Kyoko Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Kato. A scholar is included among the top collaborators of Kyoko Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Kato. Kyoko Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsubara, Yuki, Kazuhiro Toriyama, Shigenori Kadowaki, et al.. (2023). The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma. Esophagus. 20(3). 524–532. 4 indexed citations
2.
Mitani, Seiichiro, Yosuke Kito, Kentaro Kawakami, et al.. (2023). Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study. Targeted Oncology. 18(5). 707–715. 2 indexed citations
3.
Sugiyama, Keiji, et al.. (2023). Immunotherapy for Unresectable Small Bowel Adenocarcinoma: A Case Series. In Vivo. 38(1). 518–522.
4.
Kawakami, Takeshi, Toshiki Masuishi, Yasuyuki Kawamoto, et al.. (2022). The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study. Cancer Medicine. 11(11). 2184–2192. 1 indexed citations
5.
6.
Mizukami, Takuro, Masaki Takahashi, Yu Sunakawa, et al.. (2022). Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy. Targeted Oncology. 17(3). 343–353. 1 indexed citations
7.
Matsubara, Yuki, Toshiki Masuishi, Takatsugu Ogata, et al.. (2022). Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 149(3). 1123–1129. 1 indexed citations
8.
Narita, Yukiya, Takatsugu Ogata, Yuki Matsubara, et al.. (2021). Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis. Anticancer Research. 41(10). 5147–5155. 2 indexed citations
9.
Kato, Kyoko, Yukiya Narita, Seiichiro Mitani, et al.. (2020). Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer. Anticancer Research. 40(4). 2247–2255. 16 indexed citations
10.
Mitani, Seiichiro, Shigenori Kadowaki, Azusa Komori, et al.. (2020). A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies. Advances in Therapy. 37(6). 2853–2864. 5 indexed citations
11.
Mitani, Seiichiro, Shigenori Kadowaki, Kyoko Kato, Toshiki Masuishi, & Kei Muro. (2019). Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies. Case Reports in Oncology. 12(1). 304–310. 3 indexed citations
12.
Honda, Kazunori, Shigenori Kadowaki, Kyoko Kato, et al.. (2019). Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report. Investigational New Drugs. 37(4). 791–795. 30 indexed citations
13.
Hashimoto, Naoya, Seiichiro Mitani, Hiroya Taniguchi, et al.. (2018). A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer. The Oncologist. 24(2). 159–e66. 1 indexed citations
14.
Yamazaki, Takeshi, Kyoko Kato, T. Nakai, et al.. (2013). A Common Stomatal Parameter Set Used to Simulate the Energy and Water Balance over Boreal and Temperate Forests. Journal of the Meteorological Society of Japan Ser II. 91(3). 273–285. 6 indexed citations
15.
Kondo, Ryoichi, Kyoko Kato, Takashi Eguchi, et al.. (2008). A Clinical Study on Multiple Primary Cancers in Cases of Resected Lung Cancer. Haigan. 48(1). 33–38. 6 indexed citations
16.
Eguchi, Takashi, Makoto Kurai, Kyoko Kato, et al.. (2008). A case of non-tuberculous mycobacterial infection along the pulmonary suture line after partial resection for aspergilloma. The Journal of the Japanese Association for Chest Surgery. 22(1). 35–38. 3 indexed citations
17.
Eguchi, Takashi, Kyoko Kato, Takayuki Shiina, et al.. (2008). Pulmonary torsion of the lingula following a segmentectomy of the left upper division. General Thoracic and Cardiovascular Surgery. 56(10). 505–508. 16 indexed citations
18.
Kato, Kyoko & Keiko Fujiki. (1996). Incidence of congenital malformations in Tokyo Metropolitan Hospitals, 1979–1993. Brain and Development. 18(3). 230–233. 9 indexed citations
19.
Matsumoto, Takashi, et al.. (1983). Functionalization of (R)-3-(3-Acetoxypropyl)-2,3-dihydro-7-isopropyl-3,4-dimethylnaphtho[2,3-b]furan-2-one and Some Related Compounds. Bulletin of the Chemical Society of Japan. 56(10). 2985–2993. 1 indexed citations
20.
Tsuda, Hirohisa & Kyoko Kato. (1977). High rate of endoreduplications and chromosomal aberrations in hamster cells treated with sodium nitrite in vitro. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 56(1). 69–73. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihua Wu Breakdown of academic impact, for papers by Jiaying Chen Breakdown of academic impact, for papers by Xuemei Guo Breakdown of academic impact, for papers by Yesha Patel Breakdown of academic impact, for papers by Zita Bognár Breakdown of academic impact, for papers by Chunfeng Yang Breakdown of academic impact, for papers by Lillemor Lewan Breakdown of academic impact, for papers by Lisa A. Bailey Breakdown of academic impact, for papers by Xiaoge Wang Breakdown of academic impact, for papers by John Lindsley
Rankless by CCL
2026